Medical News Today1d
Anti-amyloid drug may help reduce the risk of early-onset Alzheimer's by 50%
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
CURE1d
How Antibody-Drug Conjugates Have Impacted HER2-Positive Breast Cancer Treatment
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
ScienceAlert on MSN6h
Anti-Amyloid Drug May Delay Alzheimer's Symptoms in Those at Risk, Clinical Trial Finds
A method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who ...
Asian News International on MSN23h
Anti-amyloid drug displays signs of preventing Alzheimer's dementia: Study
A new study has found that an experimental drug appears to reduce the risk of Alzheimer' s-related dementia in people ...
Scientists Announce Possible Breakthrough in Delaying Alzheimer’s
Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.
The Manila Times3d
Anti-HER2 Biparatopic ADC JSKN003 Has Been Granted Breakthrough-Therapy Designation for the Treatment of PROC
Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ('CSPC') (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has ...
CURE1d
Golidocitinib Plus PD-1 Antibodies Being Explored in Lung Cancer Subset
Findings on golidocitinib for patients with non-small cell lung cancer whose disease has progressed on anti-PD-1 therapy will ...
Science Daily1d
Anti-amyloid drug shows signs of preventing Alzheimer's dementia
An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...